Bhawna Sharma
Psychiatry · Centreville, ILNPI 1134546690
Payments from drug & device makers
Across 162 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$625
- Johnson & Johnson$575
- Otsuka America Pharmaceutical, Inc.$361
- Alkermes, Inc.$263
- Neurocrine Biosciences, Inc.$218
- Teva Pharmaceuticals USA, Inc.$190
- plus $343 from 7 others
What the payments were for
- Food & beverage$2,575100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 51 | $625 |
| Johnson & Johnson | 33 | $575 |
| Otsuka America Pharmaceutical, Inc. | 24 | $361 |
| Alkermes, Inc. | 14 | $263 |
| Neurocrine Biosciences, Inc. | 13 | $218 |
| Teva Pharmaceuticals USA, Inc. | 10 | $190 |
| E.r. Squibb & Sons, L.L.C. | 4 | $92 |
| Vanda Pharmaceuticals Inc. | 4 | $76 |
| Lundbeck LLC | 3 | $56 |
| Ironshore Pharmaceuticals Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Luye Pharma (USA) Ltd. | 1 | $25 |
| Noven Therapeutics, LLC | 1 | $19 |
How this compares
$2,575 in reported general payments places this provider in the 80th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 47 | $247,504 |
| Invega SustennaPaliperidone Palmitate | 46 | $112,029 |
| AristadaAripiprazole Lauroxil | 11 | $34,733 |
| Abilify MaintenaAripiprazole | 13 | $26,862 |
| Aripiprazole | 165 | $5,221 |
| Duloxetine Hcl | 158 | $3,494 |
| Ziprasidone Hcl | 68 | $3,305 |
| Bupropion XlBupropion Hcl | 104 | $3,051 |
| Hydroxyzine Hcl | 97 | $2,854 |
| Quetiapine Fumarate | 172 | $2,671 |
| Buspirone Hcl | 160 | $1,817 |
| Trazodone Hcl | 184 | $1,304 |
| Gabapentin | 87 | $1,298 |
| Clomipramine Hcl | 25 | $1,232 |
| Divalproex Sodium | 28 | $1,020 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $190 | $247,50447 claims |
| Johnson & JohnsonInvega Sustenna | $575 | $112,02946 claims |
| Alkermes, Inc.Aristada | $263 | $34,73311 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $361 | $26,86213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,344 psychiatry providers in Illinois.
Other psychiatry in Centreville
- Jeffrey RossNorthbrook$10.8M
- Yuhwen ChowChicago$8.5M
- Mark LermanNorthbrook$4.5M
- Danesh AlamWinfield$2.7M
- John ZajeckaSkokie$2.5M
- Riaz BaberNaperville$2.4M
- Michael GreenbaumLibertyville$2.2M
- Sandeep GaonkarNaperville$1.8M
- Jon GrantChicago$1.4M
- David KempOak Lawn$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.